IL12A and neoplasm: IL-35 expression within the TME can promote primary tumor cell growth and metastatic colonization at a secondary site (19, 20), signaling through a receptor composed of gp130 and IL-12Rβ2 to induce downstream Ebi3 and IL-12a transcription and the activation of a classical JAK-STAT signaling pathway (15, 21).